2015年美国神经科医生与产业财务关系:开放支付数据库分析
该回顾性数据库分析利用CMS开放支付数据库,评估2015年美国神经科医生从制药和器械产业获得的非研究性支付和研究性支付。约96%的神经科医生获得非研究性支付,总额$93,920,993,中位支付$407;412名医生获得研究性支付$2,921,611,中位$1,132。
要点
- 约96%美国神经科医生获非研究性支付,中位$407。
- 非研究性支付最高来自Teva Pharmaceuticals($16,461,055)。
- 412名神经科医生获研究性支付,中位$1,132。
核心结论
- 开放支付计划旨在促进产业补偿透明披露,但其对处方、成本等结局的影响尚不明确。
研究设计与样本
- 回顾性数据库分析,使用CMS开放支付数据库分析2015年美国神经科医生的产业支付。
主要发现
- 约96%美国神经科医生获得非研究性支付,总额$93,920,993,中位$407。
- 非研究性支付中食品饮料占支付笔数83%,最高金额为担任非继续医学教育活动教员/讲者(49%)。
- 非研究性支付最大赞助商为Teva Pharmaceuticals($16,461,055;17.5%)。
- 412名神经科医生获得研究性支付$2,921,611,中位$1,132。
- 研究性支付中多发性硬化专科医生获最大比例($285,537;9.7%),Daiichi Sankyo支付最多($826,029;28%)。
临床怎么用
- 神经科医生应了解开放支付数据库中的产业支付记录,关注潜在利益冲突。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyze research and nonresearch payments from the pharmaceutical and device industry to neurologists in 2015 using the Centers for Medicare and Medicaid Services (CMS) Open Payments Database. METHODS: In this retrospective database analysis, we computed the percentage of neurologists in the United States receiving payments, the median/mean payments per neurologist, payment categories, regional trends, and sponsors. We computed the number of practicing neurologists from the Association of American Medical Colleges State Physician Workforce Data Book, 2015. RESULTS: In 2015, approximately 96% of US neurologists received nonresearch payments totaling $93,920,993. The median payment per physician was $407. The highest proportion of neurologists (24%) received between $1,000 and $10,000. Food and beverage was the most frequent category (83% of the total number of payments). The highest amount was paid for serving as faculty/speaker for noncontinuing medical education activities (49%). The top sponsor of nonresearch payments was Teva Pharmaceuticals ($16,461,055; 17.5%). A total of 412 neurologists received $2,921,611 in research payments (median $1,132). Multiple sclerosis specialists received the largest proportion ($285,537; 9.7%). Daiichi Sankyo paid the largest amount in research payments ($826,029; 28%). CONCLUSIONS: The Open Payments program was established to foster transparent disclosure of physician compensations from industry, in response to legislative and public concerns of the effect of conflicts of interest on practice, education, and research. The effects of this program remain unclear and studies of changes in prescribing practices, costs, and other outcomes are necessary. CMS should ensure that incorrect information can be rectified quickly and easily.
引用
- Ahlawat A, Narayanaswami P. Financial relationships between neurologists and industry: The 2015 Open Payments database. Neurology. 2019. PMID: 31110144. doi:10.1212/WNL.0000000000007640
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。